Please assess the completion status of the following clinical trial:

Trial Title: Adrenaline for the Treatment of No-Reflow in Normotensive Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* All patients with acute coronary syndrome who developed No-reflow during PCI.~* Patients with systolic blood pressure of \> 100 mmHg.~Exclusion Criteria:~* Hypotensive patients~* Patients with Valvular or congenital heart disease.~* Patients with Atypical chest pain~* Patients with Cardiomyopathy~* Patients with Pericarditis~* Patients with Myocarditis~* Patients refused to give consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Treatment group (Type: EXPERIMENTAL): Patients receiving intracoronary adrenaline
- Control group (Type: ACTIVE_COMPARATOR): Patients receiving intracoronary adenosine

Based on this trial design, predict the completion outcome and termination type (if applicable).